Page 2 - Phage Technology News Today

What she accomplished next could easily be called miraculous.

A Texas A&M AgriLife Research study has led to the discovery of the first curative and preventive bacteriophage treatment against the pathogen Xylella fastidios

Texas A&M AgriLife receives grant to support research on bacteriophage therapy The National Institute of Allergy and Infectious Diseases, NIAID, part of the National Institutes of Health, NIH, has awarded $2.5 million in grants to support research on bacteriophage therapy, and Texas A&M AgriLife Research is among the grant recipients. Woman, Dr. Lanying Zeng, sitting in a chair at a desk in her laboratory where she is conducting a study with phages. Lanying Zeng, Ph.D., is one of the principal ...

 E-Mail The National Institute of Allergy and Infectious Diseases, NIAID, part of the National Institutes of Health, NIH, has awarded $2.5 million in grants to support research on bacteriophage therapy, and Texas A&M AgriLife Research is among the grant recipients. Woman, Dr. Lanying Zeng, sitting in a chair at a desk in her laboratory where she is conducting a study with phages. Lanying Zeng, Ph.D., is one of the principal investigators for the new NIH-funded phages study focusing on pili s...

 E-Mail A study from the Center for Phage Technology, part of Texas A&Ms College of Agriculture and Life Sciences and Texas A&M AgriLife Research, shows how the "hidden" genes in bacteriophages -- types of viruses that infect and destroy bacteria -- may be key to the development of a new class of antibiotics for human health. The study has been published in Nature Communications and Current Science Daily, as well as featured in a recent Nature Research Microbiology Community blog post. The ne...